###begin article-title 0
Vitamin D and the vitamin D receptor are critical for control of the innate immune response to colonic injury
###end article-title 0
###begin p 1
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 38 39 38 39 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 40 41 40 41 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 194 195 194 195 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 196 198 196 198 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 129 133 <span type="species:ncbi:10090">mice</span>
The active form of vitamin D (1,25(OH)2D3) has been shown to inhibit development of inflammatory bowel disease (IBD) in IL-10 KO mice. Here, the role of the vitamin D receptor (VDR) and 1,25(OH)2D3 in acute experimental IBD was probed.
###end p 3
###begin title 4
Results
###end title 4
###begin p 5
###xml 892 893 873 874 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 894 896 875 877 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 7 11 <span type="species:ncbi:10090">mice</span>
###xml 117 121 <span type="species:ncbi:10090">mice</span>
###xml 195 199 <span type="species:ncbi:10090">mice</span>
###xml 227 231 <span type="species:ncbi:10090">mice</span>
###xml 458 462 <span type="species:ncbi:10090">mice</span>
###xml 471 475 <span type="species:ncbi:10090">mice</span>
###xml 533 537 <span type="species:ncbi:10090">mice</span>
###xml 635 639 <span type="species:ncbi:10090">mice</span>
###xml 717 721 <span type="species:ncbi:10090">mice</span>
###xml 843 847 <span type="species:ncbi:10090">mice</span>
###xml 988 992 <span type="species:ncbi:10090">mice</span>
VDR KO mice were extremely sensitive to dextran sodium sulfate (DSS) and there was increased mortality of the VDR KO mice at doses of DSS that only caused a mild form of colitis in wildtype (WT) mice. DSS colitis in the VDR KO mice was accompanied by high colonic expression of TNF-alpha, IL-1 alpha, IL-1beta, IL-12, IFN-gamma, IL-10, MIP-1alpha and KC. DSS concentrations as low as 0.5% were enough to induce bleeding, ulceration and weight loss in VDR KO mice. VDR KO mice failed to recover following the removal of DSS, while WT mice showed signs of recovery within 5 days of DSS removal. The early mortality of DSS treated VDR KO mice was likely due to perforation of the bowel and resulting endotoxemia. VDR KO mice were hyper-responsive to exogenously injected LPS and cultures of the peritoneal exudates of moribund DSS treated VDR KO mice were positive for bacterial growth. 1,25(OH)2D3 in the diet or rectally decreased the severity and extent of DSS-induced inflammation in WT mice.
###end p 5
###begin title 6
Conclusion
###end title 6
###begin p 7
###xml 58 59 58 59 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 60 62 60 62 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
The data point to a critical role for the VDR and 1,25(OH)2D3 in control of innate immunity and the response of the colon to chemical injury.
###end p 7
###begin title 8
Background
###end title 8
###begin p 9
###xml 204 205 204 205 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 450 451 443 444 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
The two forms of inflammatory bowel disease (IBD): Crohn's disease and ulcerative colitis are chronic diseases characterized by aberrant responses to luminal bacteria in genetically susceptible subjects [1]. Although IBD are chronic diseases, the initiation of the inflammation and reactivations of the disease are associated with engagement of the innate immune response and progressive induction of IL-12, IL-1beta, and TNF-alpha in the intestine [2].
###end p 9
###begin p 10
###xml 177 178 177 178 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 511 512 511 512 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 581 582 581 582 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 736 737 736 737 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 738 739 738 739 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 750 751 750 751 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 752 753 752 753 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 562 570 <span type="species:ncbi:9606">patients</span>
The vitamin D receptor (VDR) is a ligand inducible transcription factor that has been shown to be an important regulator of many experimental autoimmune diseases including IBD [3]. A major source of vitamin D results from its manufacture via a photolysis reaction in the skin. Dietary intake of vitamin D is problematic since there are few foods, which are naturally rich in vitamin D. There is mounting evidence for a link between vitamin D availability either from sunshine or diet and the prevalence of IBD [3]. In addition, vitamin D deficiency is common in patients with IBD [4]. Vitamin D is biologically inactive and two hydroxylation reactions occurring in the liver and kidney result in production of active vitamin D (1,25(OH)2D3). 1,25(OH)2D3is the form of vitamin D that binds to the VDR and inhibits experimental autoimmunity.
###end p 10
###begin p 11
###xml 100 101 100 101 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 102 103 102 103 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 159 160 159 160 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 161 163 161 163 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 208 209 208 209 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 249 250 249 250 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 251 253 251 253 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 439 440 435 436 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 441 443 437 439 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 452 453 448 449 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 94 98 <span type="species:ncbi:10090">mice</span>
###xml 141 145 <span type="species:ncbi:10090">mice</span>
Vitamin D deficiency and VDR deficiency have been shown to exacerbate chronic IBD in IL-10 KO mice [5,6]. Furthermore, treatment of IL-10 KO mice with 1,25(OH)2D3 resulted in the suppression of IBD symptoms [5]. The effects of vitamin D and 1,25(OH)2D3 in IBD have begun to be explored and include direct effects of vitamin D on T cells and innate immune cells. Suppression of TNF-alpha is one mechanism underlying the efficacy of 1,25(OH)2D3 in vivo [7]. In the gut it is likely that the targets of vitamin D will include epithelial cells, innate as well as acquired immune cells.
###end p 11
###begin p 12
###xml 167 169 167 169 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 199 200 199 200 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 201 203 201 203 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 204 205 204 205 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 305 306 305 306 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 496 498 496 498 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 416 420 <span type="species:ncbi:10090">mice</span>
Macrophage are important vitamin D targets since they are a potential source of the 1 alpha hydroxylase enzyme (Cyp27B1) that converts the provitamin D hormone 25(OH)D3 to active VDR binding 1,25(OH)2D3 [8]. Macrophage expression of Cyp27B1 has been shown to be increased following TLR ligation in vitro [9]. Macrophage and the TLR pathways are critical regulators of experimental IBD. The TLR-4, TLR-2 and MyD88 KO mice are extremely susceptible to dextran sodium sulfate (DSS) induced colitis [10]. Little is known on whether vitamin D regulates these pathways to maintain gastrointestinal homeostasis in vivo.
###end p 12
###begin p 13
###xml 114 116 114 116 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 218 220 218 220 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 356 358 356 358 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 422 424 422 424 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 513 515 506 508 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 212 216 <span type="species:ncbi:10090">mice</span>
###xml 350 354 <span type="species:ncbi:10090">mice</span>
###xml 375 379 <span type="species:ncbi:10090">mice</span>
DSS initiates mucosal epithelial cell damage by disrupting barrier function, leading to ulceration, and bleeding [11]. A relatively slow mucosal repair process occurs following withdrawal of DSS in wildtype (WT) mice [11]. DSS induced colitis results due to stimulation of the innate immune response since T and B cell-deficient animals such as SCID mice [12], and also SCID mice depleted of NK cells develop DSS colitis [13]. The model is characterized by macrophage production of IL-1beta, IL-6, and TNF-alpha [13]. Macrophage induction at mucosal surfaces are early triggers in an inflammatory cascade that leads to destruction of the intestinal wall.
###end p 13
###begin p 14
###xml 32 33 32 33 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 34 36 34 36 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 292 293 292 293 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 294 296 294 296 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 107 111 <span type="species:ncbi:10090">mice</span>
###xml 230 234 <span type="species:ncbi:10090">mice</span>
###xml 385 389 <span type="species:ncbi:10090">mice</span>
###xml 487 491 <span type="species:ncbi:10090">mice</span>
The role of the VDR and 1,25(OH)2D3 in regulation of the early innate immune response to DSS was probed in mice. Expression of the VDR was found to be critical to control the innate immune response in the gut. In addition, VDR KO mice had a delayed recovery following DSS withdrawal. 1,25(OH)2D3 treatments were protective and controlled the early innate response in the colon. VDR KO mice were extremely susceptible to the TLR-4 ligand LPS and furthermore the early death of the VDR KO mice following DSS challenge was associated with bacterial recovery from the peritoneal cavity.
###end p 14
###begin title 15
Results
###end title 15
###begin title 16
###xml 37 41 <span type="species:ncbi:10090">mice</span>
Acute DSS colitis is fatal in VDR KO mice
###end title 16
###begin p 17
###xml 102 105 102 105 <sup xmlns:xlink="http://www.w3.org/1999/xlink">th </sup>
###xml 193 195 193 195 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1A</xref>
###xml 426 428 426 428 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1A</xref>
###xml 471 473 471 473 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2B</xref>
###xml 14 18 <span type="species:ncbi:10090">mice</span>
###xml 79 83 <span type="species:ncbi:10090">mice</span>
###xml 182 186 <span type="species:ncbi:10090">mice</span>
###xml 297 301 <span type="species:ncbi:10090">mice</span>
###xml 379 383 <span type="species:ncbi:10090">mice</span>
###xml 439 443 <span type="species:ncbi:10090">mice</span>
###xml 528 532 <span type="species:ncbi:10090">mice</span>
WT and VDR KO mice were induced to develop DSS colitis. At 3.5% DSS the VDR KO mice began to die the 6th day post-DSS administration and by 8 days there was 100% mortality of VDR KO mice (Fig. 1A). Severe diarrhea, bleeding and the loss of more than 25% of the BW preceded mortality of the VDR KO mice. The dosage of DSS was reduced to 2.5% DSS. The mortality of VDR KO (n = 58) mice reached over 80% by day 12 post DSS (Fig. 1A) when the mice lost 25% of their BW (Fig. 2B). At doses of either 2.5% or 3.5% DSS the WT (n = 36) mice did not die and lost only 10% of their BW while showing only mild diarrhea and bleeding.
###end p 17
###begin title 18
###xml 31 35 <span type="species:ncbi:10090">mice</span>
Delayed recovery of the VDR KO mice following removal of DSS
###end title 18
###begin p 19
###xml 89 91 89 91 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 130 132 130 132 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1B</xref>
###xml 165 167 165 167 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1C</xref>
###xml 415 417 415 417 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1B</xref>
###xml 496 498 496 498 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1C</xref>
###xml 604 606 604 606 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1C</xref>
###xml 97 101 <span type="species:ncbi:10090">mice</span>
###xml 262 266 <span type="species:ncbi:10090">mice</span>
###xml 287 291 <span type="species:ncbi:10090">mice</span>
###xml 339 343 <span type="species:ncbi:10090">mice</span>
###xml 674 678 <span type="species:ncbi:10090">mice</span>
###xml 712 716 <span type="species:ncbi:10090">mice</span>
In this acute colitis model there is a recovery phase that follows the cessation of DSS [14]. WT mice recovered body weight (Fig. 1B) and the colon lengthened (Fig. 1C) within 5 days of DSS removal as expected. The recovery phase was delayed in surviving VDR KO mice when compared to WT mice as evident by the ultimate inability of VDR KO mice to completely regain BW even 30 days after treatment was stopped (Fig. 1B). Conversely, by day 10 post DSS the WT colons had recovered completely (Fig. 1C) while the VDR KO colons were still significantly shortened and not different than 5 days post DSS (Fig. 1C). Even at lower doses of DSS (1.5%) the recovery period for VDR KO mice was 33 +/- 3.5 days while for WT mice weight was completely regained by 12+/- 1.5 days.
###end p 19
###begin title 20
###xml 7 11 <span type="species:ncbi:10090">mice</span>
VDR KO mice are sensitive to very low doses of DSS
###end title 20
###begin p 21
###xml 276 278 276 278 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1D</xref>
###xml 380 382 380 382 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1D</xref>
###xml 113 117 <span type="species:ncbi:10090">mice</span>
###xml 129 133 <span type="species:ncbi:10090">mice</span>
###xml 266 270 <span type="species:ncbi:10090">mice</span>
###xml 310 314 <span type="species:ncbi:10090">mice</span>
###xml 369 373 <span type="species:ncbi:10090">mice</span>
Very low doses of (0.5%-2%) DSS that produce little to no harm to the WT intestinal mucosa were tested in VDR KO mice. In VDR KO mice, a dose of 0.5%-1% DSS induced a loss of approximately 15%-18% of the initial BW while this dose of DSS did not affect the BW of WT mice (Fig 1D). A dose of 0.5% DSS in VDR KO mice induced the same decrease in BW as 2.5% DSS in the WT mice (Fig. 1D).
###end p 21
###begin title 22
###xml 65 69 <span type="species:ncbi:10090">mice</span>
Hematological and histological alterations in DSS-treated VDR KO mice
###end title 22
###begin p 23
###xml 240 241 240 241 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
###xml 374 376 374 376 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2A</xref>
###xml 651 653 651 653 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2B</xref>
###xml 88 92 <span type="species:ncbi:10090">mice</span>
###xml 200 204 <span type="species:ncbi:10090">mice</span>
###xml 268 272 <span type="species:ncbi:10090">mice</span>
###xml 363 367 <span type="species:ncbi:10090">mice</span>
###xml 400 404 <span type="species:ncbi:10090">mice</span>
###xml 537 541 <span type="species:ncbi:10090">mice</span>
###xml 624 628 <span type="species:ncbi:10090">mice</span>
###xml 740 744 <span type="species:ncbi:10090">mice</span>
###xml 803 807 <span type="species:ncbi:10090">mice</span>
###xml 868 872 <span type="species:ncbi:10090">mice</span>
###xml 1019 1023 <span type="species:ncbi:10090">mice</span>
Beginning with day 1 post-DSS administration, blood was detected in the feces of VDR KO mice. Multiple bleeding ulcerations of the intestinal mucosa occurred early and with greater severity in VDR KO mice following DSS administration (Fig. 3). The colon of the VDR KO mice contained blood and scored significantly higher using the colonic blood score than the WT mice (Fig. 2A). Consequently, VDR KO mice became severely anemic; demonstrated by low red blood cells and hematocrit concentrations (data not shown). In addition, the VDR KO mice had increased white blood cell counts, neutrophils and lymphocytes compared to WT mice at 5 d post-DSS (Fig. 2B). Peritoneal exudate fluid was collected and bacterial cultures were made from VDR KO mice that were either treated or not with DSS. Moribund VDR KO mice treated with DSS had positive bacterial cultures (untreated mice were negative) that prove that bacteria was translocating out of the gut and into systemic circulation (data not shown). It is likely that VDR KO mice were dying of severe bleeding and endotoxemia following perforation of the bowel induced by DSS.
###end p 23
###begin p 24
###xml 154 156 154 156 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3D</xref>
###xml 287 289 287 289 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3F</xref>
###xml 400 401 400 401 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
###xml 554 556 554 556 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3F</xref>
###xml 674 676 674 676 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3H</xref>
###xml 914 915 914 915 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4</xref>
###xml 451 456 <span type="species:ncbi:10090">mouse</span>
###xml 738 742 <span type="species:ncbi:10090">mice</span>
###xml 764 768 <span type="species:ncbi:10090">mice</span>
At 3.5 % DSS the VDR KO colon showed a complete destruction of the mucosal surface with most of the epithelium lost and few intact crypts remaining (Fig. 3D). At lower doses of DSS the mucosal damage was less although there were isolated areas where the mucosal surface was absent (Fig. 3F). Both the VDR KO and WT sections showed signs of inflammation and thickening in the outer colonic wall (Fig. 3); however the extent of the damage to the VDR KO mouse was more extensive and failed to resolve. Edema was evident in many of the VDR KO sections (Fig. 3F) and there were significant amounts of blood in the colon after 10 days of DSS but only in the VDR KO sections (Fig. 3H). Blinded scoring of the histopathology sections from VDR KO mice indicate that VDR KO mice had significantly more inflammation, injury and crypt damage than their WT counterparts at both 5 and 10 days post 2.5% DSS administration (Fig. 4, *P < 0.05).
###end p 24
###begin title 25
###xml 57 61 <span type="species:ncbi:10090">mice</span>
Over-expression of many cytokines in the colon of VDR KO mice treated with DSS
###end title 25
###begin p 26
###xml 125 126 114 115 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5</xref>
###xml 226 227 215 216 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5</xref>
###xml 477 478 455 456 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5</xref>
###xml 29 33 <span type="species:ncbi:10090">mice</span>
###xml 195 199 <span type="species:ncbi:10090">mice</span>
###xml 215 219 <span type="species:ncbi:10090">mice</span>
###xml 263 267 <span type="species:ncbi:10090">mice</span>
###xml 436 440 <span type="species:ncbi:10090">mice</span>
Colonic extracts from VDR KO mice treated with DSS showed high levels of TNFalpha, IL-12, IL-10, IL-1alpha and IL-1beta (Fig 5). The levels of these cytokines were significantly higher in VDR KO mice compared to WT mice (Fig. 5). By 10 days post-DSS treatment WT mice had very little IL-10, IL-1alpha, and IL-1beta and no detectable levels of IL-12, and TNF-alpha while the levels in the VDR KO colons remained elevated even though the mice had been fed water for 5 days (Fig. 5).
###end p 26
###begin p 27
###xml 308 309 308 309 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5</xref>
###xml 464 465 464 465 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5</xref>
###xml 592 593 592 593 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5</xref>
###xml 753 754 753 754 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5</xref>
###xml 133 137 <span type="species:ncbi:10090">mice</span>
###xml 350 354 <span type="species:ncbi:10090">mice</span>
###xml 433 437 <span type="species:ncbi:10090">mice</span>
###xml 453 457 <span type="species:ncbi:10090">mice</span>
###xml 554 558 <span type="species:ncbi:10090">mice</span>
###xml 622 627 <span type="species:ncbi:10090">mouse</span>
###xml 671 675 <span type="species:ncbi:10090">mice</span>
###xml 742 746 <span type="species:ncbi:10090">mice</span>
Chemokines recruit neutrophils, macrophage and other effector immune cells to the site of injury. While, the colons of WT and VDR KO mice produced undetectable levels of KC-1, and MIP-1 prior to DSS administration (data not shown); KC-1 and MIP-1 were detectable 5 days after the administration of DSS (Fig. 5) in the colon of both the VDR KO and WT mice. MIP-1 was significantly higher at 5 and 10 days post DSS treatment in VDR KO mice compared to WT mice (Fig. 5). KC production was increased to a similar level in colonic extracts from VDR KO and WT mice 5 days after DSS treatment (Fig. 5) and then decreased in both mouse types by day 10. However, at day 10 VDR KO mice had significantly higher levels of KC in the colon compared to WT mice (Fig. 5).
###end p 27
###begin title 28
###xml 29 33 <span type="species:ncbi:10090">mice</span>
Lethal endotoxemia in VDR KO mice
###end title 28
###begin p 29
###xml 294 295 294 295 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6</xref>
###xml 713 715 713 715 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p </italic>
###xml 34 38 <span type="species:ncbi:10090">mice</span>
###xml 152 156 <span type="species:ncbi:10090">mice</span>
###xml 182 186 <span type="species:ncbi:10090">mice</span>
###xml 353 357 <span type="species:ncbi:10090">mice</span>
###xml 480 484 <span type="species:ncbi:10090">mice</span>
###xml 556 560 <span type="species:ncbi:10090">mice</span>
###xml 664 668 <span type="species:ncbi:10090">mice</span>
###xml 768 772 <span type="species:ncbi:10090">mice</span>
The increased lethality of VDR KO mice following DSS-administration may be a result of endotoxemia following perforation of the large intestine. VDR KO mice (n = 11) and WT (n = 10) mice were injected with the bacterial outer wall component LPS and survival was assessed daily for 7 days (Fig. 6). Shortly after intravenous administration of LPS VDR KO mice became extremely ill, experiencing diarrhea, hunched posture, shaking and lethargy. Similar results were seen when VDR KO mice were injected ip using the same doses of LPS. Eighty percent of VDR KO mice died during the first 4 days post-injection and only 20% survived to day 7. In contrast, 70% of the WT mice survived through day 7 after LPS injection (p < 0.001). PBS-injected VDR KO (n = 3) and WT (n = 3) mice remained healthy throughout the 7-day study (data not shown).
###end p 29
###begin title 30
###xml 9 10 9 10 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 11 13 11 13 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 52 56 <span type="species:ncbi:10090">mice</span>
1,25 (OH)2D3 improves symptoms of DSS colitis in WT mice
###end title 30
###begin p 31
###xml 31 32 31 32 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 33 35 33 35 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 181 182 181 182 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 183 185 183 185 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 295 297 295 297 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7A</xref>
###xml 374 376 374 376 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7B</xref>
###xml 500 501 496 497 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 502 503 498 499 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 585 586 581 582 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 587 589 583 585 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 685 686 681 682 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 687 689 683 685 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 768 769 764 765 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 770 772 766 768 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 830 831 826 827 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 832 834 828 830 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 873 875 869 871 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7C</xref>
###xml 880 882 876 878 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7D</xref>
###xml 918 919 914 915 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 920 921 916 917 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 956 957 952 953 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 958 960 954 956 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 1031 1032 1027 1028 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 1033 1035 1029 1031 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 1079 1081 1075 1077 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7C</xref>
###xml 1170 1172 1166 1168 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7D</xref>
###xml 1232 1233 1228 1229 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 1234 1236 1230 1232 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 59 64 <span type="species:ncbi:10090">mouse</span>
###xml 137 141 <span type="species:ncbi:10090">mice</span>
###xml 520 524 <span type="species:ncbi:10090">mice</span>
###xml 593 597 <span type="species:ncbi:10090">mice</span>
###xml 854 858 <span type="species:ncbi:10090">mice</span>
Oral administration of 1,25(OH)2D3 (total dose of 1,400 ng/mouse) had no effect on the wasting associated with DSS induced colitis in WT mice (data not shown). However, the 1,25(OH)2D3 feeding significantly up-regulated IL-10 production in colonic homogenate at 14 days post-DSS induction (Fig. 7A) and this was associated with decreased total histopathological score (Fig. 7B). There was no difference in other cytokines (IL-1, TNF-alpha or IL-12) measured in the colonic homogenate between 1,25(OH)2D3-fed and control mice (data not shown). The calcium level in the blood of 1,25(OH)2D3 fed mice and controls were not different at the end of the experiment (data not shown). 1,25(OH)2D3 (10 ng, 10 IU) was administered intra-rectally so that delivery of the 1,25(OH)2D3 dose was to the site of inflammation (colon). The 1,25(OH)2D3 treated (1,25D3) WT mice shown in Fig. 7C and 7D received a total of 600 ng 1,25(OH)2D3. Rectal administration of 1,25(OH)2D3 did not affect serum calcium values (data not shown) while the 1,25(OH)2D3 treatment prevented body weight loses (Fig. 7C) and resulted in microscopic improvement in histology scores compared to controls (Fig. 7D). Rectal treatment was more effective than feeding 1,25(OH)2D3 for decreasing the severity of DSS colitis since the same result occurred using only half the dose rectally.
###end p 31
###begin title 32
Discussion
###end title 32
###begin p 33
###xml 602 604 602 604 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 681 683 681 683 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 684 686 684 686 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 852 854 852 854 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 855 857 855 857 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 30 34 <span type="species:ncbi:10090">mice</span>
###xml 116 120 <span type="species:ncbi:10090">mice</span>
###xml 540 544 <span type="species:ncbi:10116">rats</span>
###xml 596 600 <span type="species:ncbi:10116">rats</span>
###xml 610 616 <span type="species:ncbi:9606">humans</span>
###xml 708 716 <span type="species:ncbi:9606">patients</span>
###xml 874 878 <span type="species:ncbi:10090">mice</span>
###xml 999 1003 <span type="species:ncbi:10090">mice</span>
###xml 1124 1128 <span type="species:ncbi:10090">mice</span>
###xml 1232 1236 <span type="species:ncbi:10090">mice</span>
Absence of the VDR results in mice that are extremely susceptible to chemical injury in the gut. DSS treated VDR KO mice are anemic, have high white blood cell counts, large amounts of blood in the colon, and many inflammatory cytokines expressed at high levels. A breach in the intestinal mucosa would lead to the entry of bacteria into the blood stream followed by an excessive, uncontrolled, systemic inflammation including, at the extreme, septic shock. Masubuchi et. al have shown that endotoxin levels detected in the portal blood of rats treated with DSS were higher than those in control rats [15]. In humans, systemic endotoxemia has been described in ulcerative colitis [16,17] and Crohn's disease patients and shown to correlate positively with disease activity, pro-inflammatory cytokine production and the extent of intestinal ulceration [18-23]. VDR deficient mice are extremely sensitive to intravenous or intraperitoneal administration of LPS, supporting the possibility that VDR KO mice with colitis die due to endotoxemia. In addition, bacteria was cultured from the peritoneal cavities of moribund VDR KO mice following DSS treatment. All of the data support the hypothesis that the early mortality of the VDR KO mice treated with DSS is due to perforation of the gut and resulting endotoxemia.
###end p 33
###begin p 34
###xml 71 73 71 73 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 184 186 184 186 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 359 361 359 361 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 402 404 402 404 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 417 419 417 419 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 469 471 469 471 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 482 483 482 483 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 484 486 484 486 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 617 619 617 619 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 643 644 643 644 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 645 647 645 647 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 745 747 745 747 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 890 892 890 892 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 1156 1158 1156 1158 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 1445 1447 1445 1447 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
###xml 1479 1480 1479 1480 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 1481 1483 1481 1483 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 395 400 <span type="species:ncbi:9606">human</span>
###xml 410 415 <span type="species:ncbi:10090">mouse</span>
###xml 1004 1008 <span type="species:ncbi:10090">mice</span>
###xml 1217 1221 <span type="species:ncbi:10090">mice</span>
DSS induced colitis is a chemical that damages the colonic epithelium [24] with subsequent recruitment and activation of inflammatory cells and upregulation of inflammatory mediators [25]. During injury or inflammation, intestinal epithelial cells are rapidly proliferating and this process of mucosal repair and regeneration is critical for gut homeostasis [26]. The VDR is highly expressed in human [27] and mouse [28] colonic mucosa and intestinal epithelial cells [29]. 1,25(OH)2D3 has been shown to control normal villus and crypt development by regulating proliferation and differentiation of intestinal cells [30]. Furthermore, 1,25(OH)2D3 is an important regulator of cell growth and differentiation in many tissues including the colon [31]. In DSS colitis most of the pathological changes are localized to the distal colon which is a site of low proliferation of epithelial cells [31]. Others have shown that the baseline proliferative state of colonic eptithelial cells in the crypts of VDR KO mice are elevated and showed increased expression of markers for cycling cells (proliferating cell nuclear antigen and cyclin D1) when compared to WTs [31]. Although increased proliferation in the colon of VDR KO mice might be seen as beneficial, it has been shown that crypts with increased numbers of epithelial cells in cell cycle are more susceptible to radiation-induced injury as determined by their inability to repopulate the crypt [32]. The effectiveness of 1,25(OH)2D3 in protecting the colon and the heightened susceptibility of the VDR KO gut to DSS colitis is likely due in part to the importance of vitamin D and VDR signaling in control of epithelial growth and proliferation.
###end p 34
###begin p 35
###xml 539 541 516 518 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B33">33</xref>
###xml 644 646 617 619 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B34">34</xref>
###xml 781 783 746 748 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B35">35</xref>
###xml 373 377 <span type="species:ncbi:10090">mice</span>
###xml 417 421 <span type="species:ncbi:10090">mice</span>
###xml 423 428 <span type="species:ncbi:9606">Human</span>
###xml 547 553 <span type="species:ncbi:9606">humans</span>
###xml 595 603 <span type="species:ncbi:9606">patients</span>
###xml 656 660 <span type="species:ncbi:10090">mice</span>
###xml 886 890 <span type="species:ncbi:10090">mice</span>
###xml 947 951 <span type="species:ncbi:10090">mice</span>
###xml 1026 1030 <span type="species:ncbi:10090">mice</span>
###xml 1165 1169 <span type="species:ncbi:10090">mice</span>
Once the mucosal barrier is breached, the submucosa is exposed to a vast pool of luminal antigens, including foods and bacteria, and the innate immune responses are engaged to produce large amounts of cytokines. Analysis of cytokine production by colonic homogenates revealed significant elevation of TNF-alpha, IL-1alpha, IL-1beta, IL-12p70, IFN-gamma and IL-10 in VDR KO mice treated with DSS when compared with WT mice. Human and animal studies support the idea that TNF-alpha and IFN-gamma are important pathological mediators of IBD [33]. In humans with IBD approximately two thirds of the patients responded to anti-TNF-alpha treatments [34], and in mice the intestinal inflammation was significantly attenuated by anti-IFN-gamma and/or anti-TNF-alpha monoclonal antibodies [35]. The production of IFN-gamma, TNF-alpha, IL-1alpha and IL-1beta in the colonic homogenates of VDR KO mice was substantially higher at 10 days post-DSS than in WT mice consistent with the observed delay in recovery from inflammation in these mice. The prolonged expression of inflammatory cytokines corresponded with the increased susceptibility and delayed recovery of the VDR KO mice.
###end p 35
###begin p 36
###xml 291 293 283 285 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B36">36</xref>
###xml 448 450 436 438 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B37">37</xref>
###xml 429 437 <span type="species:ncbi:9606">patients</span>
During experimental colitis members of the alpha-chemokine family are involved in the recruitment of immune cells and the development of intestinal inflammation. Ajuebor et. al have shown in experimental IBD that colonic KC and MIP-1alpha expression led to leukocyte recruitment in the gut [36]. Furthermore studies by Banks et. al showed that the expression of MIP-1alpha correlated with the severity of colonic inflammation in patients with IBD [37]. The increased levels of KC and MIP-1alpha in the colons of VDR KO suggest that in the absence of the VDR many more inflammatory cells may be recruited to the site of injury and then produce inflammatory cytokines that result in severe and fatal form of colitis.
###end p 36
###begin p 37
###xml 8 9 8 9 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 10 12 10 12 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 96 97 96 97 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 98 100 98 100 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 280 281 280 281 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 282 284 282 284 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 418 420 415 417 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B38">38</xref>
###xml 555 557 552 554 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B39">39</xref>
###xml 601 603 598 600 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B40">40</xref>
###xml 681 682 678 679 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 683 685 680 682 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 780 782 777 779 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B38">38</xref>
###xml 82 86 <span type="species:ncbi:10090">mice</span>
###xml 111 115 <span type="species:ncbi:10090">mice</span>
###xml 516 520 <span type="species:ncbi:10090">mice</span>
1,25(OH)2D3 treatments both in the food or locally reduced colitis symptoms in WT mice. 1,25(OH)2D3 treated WT mice had increased IL-10 production that might serve to inhibit other cytokine responses and lead to a dampening of the cytokine storm in the colon. Furthermore 1,25(OH)2D3 has the ability to directly induce antimicrobial gene expression and activity of antimicrobial peptide CAMP and defensin beta2 genes [38]. CAMP is a potent antisepsis agent that blocks macrophage induction, enhances the survival of mice treated with lethal doses of LPS [39] and accelerates epithelial wound healing [40]. The induction of CAMP and other antimicrobial genes suggested that 1,25(OH)2D3 might be protective against sepsis after injury and might accelerate epithelial wound healing [38].
###end p 37
###begin title 38
Conclusion
###end title 38
###begin p 39
###xml 35 36 35 36 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 37 39 37 39 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
A model develops where the 1,25(OH)2D3 that is either produced or administered locally in the colon increases epithelial cell resistance to injury and suppresses innate immune responses to luminal antigens through VDR signaling. In the absence of the VDR inflammation in the gut is amplified, colonic epithelial cell proliferation is unregulated and the host fails to adequately maintain gastrointestinal integrity following chemical insult. The data identify vitamin D as a key regulator of gastrointestinal homeostasis and an important player in regulation of the innate immune response.
###end p 39
###begin title 40
Methods
###end title 40
###begin title 41
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
Mice
###end title 41
###begin p 42
Weight (20-25 g) and sex matched 10-12 week old C57BL/6 WT and VDR KO (C57BL/6, gift from M. Demay, Harvard University, Cambridge, MA) were bred for use at the Pennsylvania State University (University Park, PA). All procedures were reviewed and approved by the Pennsylvania State University Institutional Animal Care and Use Committee.
###end p 42
###begin title 43
Induction of colitis
###end title 43
###begin p 44
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
###xml 169 173 <span type="species:ncbi:10090">mice</span>
###xml 357 361 <span type="species:ncbi:10090">mice</span>
###xml 365 369 <span type="species:ncbi:10090">mice</span>
Mice were administered 0.5%-3.5% DSS (MW = 40 kDa; ICN Biomedicals, Aurora, OH) dissolved in filter-purified and sterilized water ad libitum for 5 days, after which the mice were resumed on water for the remainder of the experiment. Animals were weighed daily and monitored clinically for rectal bleeding, diarrhea, and general signs of morbidity. Moribund mice or mice that had lost more than 25% of their body weight were sacrificed and listed as dead following induction of DSS colitis.
###end p 44
###begin title 45
Colitis symptoms
###end title 45
###begin p 46
###xml 78 80 78 80 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B41">41</xref>
###xml 440 442 440 442 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
The gross colonic blood scoring system previously described by Siegmund et al[41] was used. The colonic bleeding score was as follows: 0- no visible blood in the entire colon, 1-blood detected in less than 1/3 of the colon, 2- blood detected in less than 2/3 of the colon, 3- blood visible throughout the entire colon. The entire colon from cecum to anus was removed and the length was measured and reported as colonic length as described [11].
###end p 46
###begin p 47
###xml 717 719 717 719 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B42">42</xref>
###xml 39 43 <span type="species:ncbi:10090">mice</span>
The distal colon were removed from the mice, fixed in 10% formalin and sent to the Pennslyvania State University Animal Diagnostic Laboratories (University Park, PA) for H&E staining. Histological analysis was performed blinded by 2 independent investigators on a scale from 0 to 40 as follows: severity of inflammation (0-3: none, slight, moderate, severe), extent of injury (0-3: none, mucosal, mucosal and submucosal, transmural), and crypt damage (0-4: none, basal 1/3 damaged, basal 2/3 damaged, only surface epithelium intact, entire crypt and epithelium lost). Each score was then multiplied by a factor equivalent with the percentage of tissue involvement (x 1: 0-25%, x 2: 26-50%, x 3: 51-75%, x 4: 76-100%)[42].
###end p 47
###begin title 48
Peripheral blood analysis
###end title 48
###begin p 49
Blood was collected by cardiac puncture in tubes coated with EDTA (Becton Dickinson Vacutainer System, NJ) and analyzed using an ADVIA 120 Hematology System (Bayer Diagnostic, NY). For some experiments 100-200 mul of blood was collected by retroorbital sinus bleeding using heparinized microcapillary pipettes.
###end p 49
###begin title 50
Colonic homogenate
###end title 50
###begin p 51
###xml 272 274 271 273 <italic xmlns:xlink="http://www.w3.org/1999/xlink">g </italic>
The distal colon was weighed and the same amount of tissue was cut open and washed in 1XPBS containing penicillin (100 U/ml) and streptomycin (100 mug/ml). Tissue was then homogenized in 1 ml PBS using a razor blade. The homogenized colon tissue was centrifuged at 10,000 g at 4degreesC for 10 min. Cytokine concentrations were determined in the supernatant.
###end p 51
###begin title 52
Cytokine and chemokine ELISA
###end title 52
###begin p 53
###xml 40 45 <span type="species:ncbi:10090">mouse</span>
Serum and supernatants were assayed for mouse TNF-alpha, IL-12p70, IFN-gamma, IL-1alpha, IL-1beta, IL-10 production using Ab pairs and standards provided in the BD Pharmingen kits ELISA (San Diego, CA) according to the manufacturer's instructions. For KC and MIP-1alpha the ELISA kits were from R&D Systems. (Minneapolis, MN). The limits of detection were 31 pg/ml TNF-alpha, 125 pg/ml IL-12 p70,125 pg/ml IFN-gamma, 31 pg/ml IL-1alpha, 31 pg/ml IL-1beta, 31 pg/ml IL-10, 16 pg/ml KC and 31 pg/ml MIP-1alpha.
###end p 53
###begin title 54
Endotoxic shock
###end title 54
###begin p 55
###xml 50 67 50 67 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Escherichia coli </italic>
###xml 8 12 <span type="species:ncbi:10090">mice</span>
###xml 50 66 <span type="species:ncbi:562">Escherichia coli</span>
###xml 132 136 <span type="species:ncbi:10090">Mice</span>
C57BL/6 mice were injected iv or ip with LPS from Escherichia coli 0111:B4 (Sigma, St Louis, MO) at a dose of 10 mg/kg body weight. Mice were monitored 3-4 times daily during endotoxic shock, and moribund animals were sacrificed.
###end p 55
###begin title 56
###xml 8 9 8 9 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 10 12 10 12 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
1,25(OH)2D3 treatment
###end title 56
###begin p 57
###xml 37 38 37 38 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 39 41 39 41 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 67 68 67 68 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 166 167 166 167 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 168 170 168 170 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
###xml 193 197 <span type="species:ncbi:381124">corn</span>
###xml 337 341 <span type="species:ncbi:10090">mice</span>
###xml 398 402 <span type="species:ncbi:381124">corn</span>
Mice received 50 ng/daily of 1,25(OH)2D3 in the diet as described [5] elsewhere 1 week prior and throughout DSS administration. For local treatment, 50 ng of 1,25(OH)2D3 was dissolved in 20 uL corn oil and administered rectally 1 day prior to DSS administration and every other day thereafter for the duration of the experiment. Control mice received the corresponding amount of ethanol diluted in corn oil.
###end p 57
###begin title 58
Statistical analysis
###end title 58
###begin p 59
Statistical analysis was performed using the paired Student's t test and ANOVAs (StatView; SAS Institute, Cary, NC). P values < 0.05 were considered significant. Error bars represent +/- SEM. The log-rank test was used to compare Kaplan-Meier survival curves.
###end p 59
###begin title 60
Abbreviations
###end title 60
###begin p 61
###xml 0 5 0 5 <bold xmlns:xlink="http://www.w3.org/1999/xlink">DSS: </bold>
###xml 28 33 28 33 <bold xmlns:xlink="http://www.w3.org/1999/xlink">IBD: </bold>
###xml 60 64 60 64 <bold xmlns:xlink="http://www.w3.org/1999/xlink">KO: </bold>
###xml 73 78 73 78 <bold xmlns:xlink="http://www.w3.org/1999/xlink">VDR: </bold>
###xml 97 101 97 101 <bold xmlns:xlink="http://www.w3.org/1999/xlink">WT: </bold>
DSS: dextran sodium sulfate IBD: inflammatory bowel disease KO: knockout VDR: vitamin D receptor WT: wild type
###end p 61
###begin title 62
Authors' contributions
###end title 62
###begin p 63
MF carried out the studies, participated in the design of the study, performed the analyses and drafted the manuscript. MTC conceived of the study, participated in its design and coordination and helped to draft the manuscript. Both authors read and approved the final manuscript.
###end p 63
###begin title 64
Acknowledgements
###end title 64
###begin p 65
This work was supported by the Crohn's and Colitis Foundation of America, Predoctoral Research Award (to MF) and National Institutes of Health-National Institute of Neurological Disorders and Stroke Grant 1R01 NS38888 (to MTC).
###end p 65
###begin article-title 66
The immunological and genetic basis of inflammatory bowel disease
###end article-title 66
###begin article-title 67
###xml 26 32 <span type="species:ncbi:10090">murine</span>
Characterisation of acute murine dextran sodium sulphate colitis: cytokine profile and dose dependency
###end article-title 67
###begin article-title 68
Mounting evidence for vitamin D as an environmental factor affecting autoimmune disease prevalence
###end article-title 68
###begin article-title 69
Vitamin D and autoimmunity: is vitamin D status an environmental factor affecting autoimmune disease prevalence?
###end article-title 69
###begin article-title 70
###xml 80 86 <span type="species:ncbi:10090">murine</span>
1,25-Dihydroxycholecalciferol prevents and ameliorates symptoms of experimental murine inflammatory bowel disease
###end article-title 70
###begin article-title 71
A crucial role for the vitamin D receptor in experimental inflammatory bowel diseases
###end article-title 71
###begin article-title 72
Calcium and 1alpha,25-dihydroxyvitamin D3 target the TNF-alpha pathway to suppress experimental inflammatory bowel disease
###end article-title 72
###begin article-title 73
###xml 43 48 <span type="species:ncbi:9606">human</span>
Synthesis of 1,25-dihydroxyvitamin D(3) by human endothelial cells is regulated by inflammatory cytokines: a novel autocrine determinant of vascular cell adhesion
###end article-title 73
###begin article-title 74
###xml 54 59 <span type="species:ncbi:9606">human</span>
Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response
###end article-title 74
###begin article-title 75
Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis
###end article-title 75
###begin article-title 76
###xml 97 101 <span type="species:ncbi:10090">mice</span>
A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice
###end article-title 76
###begin article-title 77
###xml 77 81 <span type="species:ncbi:10090">mice</span>
###xml 151 155 <span type="species:ncbi:10090">mice</span>
Dextran sulfate sodium (DSS) induced experimental colitis in immunodeficient mice: effects in CD4(+) -cell depleted, athymic and NK-cell depleted SCID mice
###end article-title 77
###begin article-title 78
###xml 81 85 <span type="species:ncbi:10090">mice</span>
Dextran sulfate sodium-induced colitis occurs in severe combined immunodeficient mice
###end article-title 78
###begin article-title 79
###xml 85 100 <span type="species:ncbi:10090">transgenic mice</span>
Enhanced survival and mucosal repair after dextran sodium sulfate-induced colitis in transgenic mice that overexpress growth hormone
###end article-title 79
###begin article-title 80
###xml 113 116 <span type="species:ncbi:10116">rat</span>
Endotoxin-mediated disturbance of hepatic cytochrome P450 function and development of endotoxin tolerance in the rat model of dextran sulfate sodium-induced experimental colitis
###end article-title 80
###begin article-title 81
Bacteriological and endotoxin studies in cases of ulcerative colitis submitted to surgery
###end article-title 81
###begin article-title 82
###xml 40 48 <span type="species:ncbi:9606">patients</span>
Immune abnormalities and endotoxemia in patients with ulcerative colitis and in their first degree relatives: attempts at neutralizing endotoxin-mediated effects
###end article-title 82
###begin article-title 83
Enteral and parenteral anti-endotoxin treatment in experimental colitis
###end article-title 83
###begin article-title 84
A study of endotoxemia in ulcerative colitis and Crohn's disease. I. Clinical study
###end article-title 84
###begin article-title 85
A study of endotoxemia in ulcerative colitis and Crohn's disease. II. Experimental study
###end article-title 85
###begin article-title 86
Endotoxin and bacteria in portal blood
###end article-title 86
###begin article-title 87
Significance of systemic endotoxaemia in inflammatory bowel disease
###end article-title 87
###begin article-title 88
Enteric bacteria, lipopolysaccharides and related cytokines in inflammatory bowel disease: biological and clinical significance
###end article-title 88
###begin article-title 89
###xml 74 80 <span type="species:ncbi:10090">murine</span>
Tissue distribution of dextran sulfate sodium (DSS) in the acute phase of murine DSS-induced colitis
###end article-title 89
###begin article-title 90
Chronic experimental colitis induced by dextran sulphate sodium (DSS) is characterized by Th1 and Th2 cytokines
###end article-title 90
###begin article-title 91
###xml 11 28 <span type="species:ncbi:613112">Boswellia serrata</span>
###xml 32 37 <span type="species:ncbi:10090">mouse</span>
Effects of Boswellia serrata in mouse models of chemically induced colitis
###end article-title 91
###begin article-title 92
###xml 84 89 <span type="species:ncbi:9606">human</span>
25-Hydroxyvitamin D(3)-1alpha-hydroxylase and vitamin D receptor gene expression in human colonic mucosa is elevated during early cancerogenesis
###end article-title 92
###begin article-title 93
###xml 86 90 <span type="species:ncbi:10090">mice</span>
Vitamin D receptor is required to control gastrointestinal immunity in IL-10 knockout mice
###end article-title 93
###begin article-title 94
Extrarenal expression of 25-hydroxyvitamin d(3)-1 alpha-hydroxylase
###end article-title 94
###begin article-title 95
The role of vitamin D in bone and intestinal cell differentiation
###end article-title 95
###begin article-title 96
###xml 50 55 <span type="species:ncbi:10090">mouse</span>
Characterization of a vitamin D receptor knockout mouse as a model of colorectal hyperproliferation and DNA damage
###end article-title 96
###begin article-title 97
Protection against mucosal injury by growth factors and cytokines
###end article-title 97
###begin article-title 98
Role of cytokines in the pathogenesis of inflammatory bowel disease
###end article-title 98
###begin article-title 99
A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease. Crohn's Disease cA2 Study Group
###end article-title 99
###begin article-title 100
###xml 171 175 <span type="species:ncbi:10090">mice</span>
Interferon-gamma (IFN-gamma)- and tumour necrosis factor (TNF)-induced nitric oxide as toxic effector molecule in chronic dextran sulphate sodium (DSS)-induced colitis in mice
###end article-title 100
###begin article-title 101
Role of chemokines and chemokine receptors in the gastrointestinal tract
###end article-title 101
###begin article-title 102
Chemokine expression in IBD. Mucosal chemokine expression is unselectively increased in both ulcerative colitis and Crohn's disease
###end article-title 102
###begin article-title 103
Cutting edge: 1,25-dihydroxyvitamin D3 is a direct inducer of antimicrobial peptide gene expression
###end article-title 103
###begin article-title 104
###xml 4 9 <span type="species:ncbi:9606">human</span>
The human antimicrobial peptide LL-37 is a multifunctional modulator of innate immune responses
###end article-title 104
###begin article-title 105
###xml 85 90 <span type="species:ncbi:9606">human</span>
The cathelicidin anti-microbial peptide LL-37 is involved in re-epithelialization of human skin wounds and is lacking in chronic ulcer epithelium
###end article-title 105
###begin article-title 106
IL-1 beta -converting enzyme (caspase-1) in intestinal inflammation
###end article-title 106
###begin article-title 107
Apolipoprotein A-IV inhibits experimental colitis
###end article-title 107
###begin title 108
Figures and Tables
###end title 108
###begin p 109
###xml 0 63 0 63 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Increased mortality of VDR KO mice following DSS administration</bold>
###xml 65 68 65 68 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A) </bold>
###xml 260 263 260 263 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B) </bold>
###xml 410 413 410 413 <bold xmlns:xlink="http://www.w3.org/1999/xlink">C) </bold>
###xml 507 510 507 510 <bold xmlns:xlink="http://www.w3.org/1999/xlink">D) </bold>
###xml 30 34 <span type="species:ncbi:10090">mice</span>
###xml 101 105 <span type="species:ncbi:10090">mice</span>
###xml 145 149 <span type="species:ncbi:10090">mice</span>
###xml 212 216 <span type="species:ncbi:10090">mice</span>
###xml 305 309 <span type="species:ncbi:10090">Mice</span>
###xml 356 360 <span type="species:ncbi:10090">mice</span>
###xml 501 505 <span type="species:ncbi:10090">mice</span>
###xml 517 521 <span type="species:ncbi:10090">mice</span>
###xml 555 559 <span type="species:ncbi:10090">mice</span>
###xml 703 707 <span type="species:ncbi:10090">mice</span>
###xml 771 775 <span type="species:ncbi:10090">mice</span>
Increased mortality of VDR KO mice following DSS administration. A) Survival curves in VDR KO and WT mice induced to develop DSS colitis. VDR KO mice died following 2.5% or 3.5% DSS treatment while all of the WT mice survived regardless of DSS concentrations. B) BW recovery over time post-DSS treatment. Mice were treated with 2.5% DSS for 5 days. VDR KO mice failed to recover BW following cessation of DSS. C) Colon length at day 0 (control-CTRL), day 5 and day 10 of DSS-exposure in WT and VDR KO mice. D) VDR KO mice were administered 0.5%-2% and WT mice received 1-2% DSS (n = 5/group). BW changes were monitored, and the values are expressed as the percentage of original BW. *Values from VDR KO mice were significantly different than corresponding values from WT mice. ** WT day 10 colon lengths were significantly longer than WT day 5 colon lengths.
###end p 109
###begin p 110
###xml 0 91 0 91 <bold xmlns:xlink="http://www.w3.org/1999/xlink">VDR KO mice have blood in the colon and altered white blood cell values compared to WT mice</bold>
###xml 93 96 93 96 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A) </bold>
###xml 308 311 308 311 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B) </bold>
###xml 7 11 <span type="species:ncbi:10090">mice</span>
###xml 87 91 <span type="species:ncbi:10090">mice</span>
###xml 168 172 <span type="species:ncbi:10090">mice</span>
###xml 350 354 <span type="species:ncbi:10090">mice</span>
VDR KO mice have blood in the colon and altered white blood cell values compared to WT mice. A) Colonic blood score as a function of time post-DSS. Two WT and 2 VDR KO mice were sacrificed each day after 2.5% DSS administration and colonic blood score was assessed as described in the Materials and Methods. B) Hematological changes in WT and VDR KO mice following 2.5% DSS administration. Error bars represent +/- SEM. * WT and VDR KO values were significantly different.
###end p 110
###begin p 111
###xml 0 48 0 48 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Colitis development following DSS administration</bold>
###xml 126 129 126 129 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A) </bold>
###xml 136 139 136 139 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B) </bold>
###xml 168 171 168 171 <bold xmlns:xlink="http://www.w3.org/1999/xlink">C) </bold>
###xml 178 181 178 181 <bold xmlns:xlink="http://www.w3.org/1999/xlink">D) </bold>
###xml 226 229 226 229 <bold xmlns:xlink="http://www.w3.org/1999/xlink">E) </bold>
###xml 236 239 236 239 <bold xmlns:xlink="http://www.w3.org/1999/xlink">F) </bold>
###xml 274 277 274 277 <bold xmlns:xlink="http://www.w3.org/1999/xlink">G) </bold>
###xml 284 287 284 287 <bold xmlns:xlink="http://www.w3.org/1999/xlink">H) </bold>
###xml 146 150 <span type="species:ncbi:10090">mice</span>
###xml 188 192 <span type="species:ncbi:10090">mice</span>
###xml 246 250 <span type="species:ncbi:10090">mice</span>
###xml 294 298 <span type="species:ncbi:10090">mice</span>
Colitis development following DSS administration. Representative sections and histological assessment of colonic samples from A) WT and B) VDR KO mice receiving water; C) WT and D) VDR KO mice 5 days after receiving 3.5% DSS; E) WT and F) VDR KO mice 5 days after 2.5% DSS; G) WT and H) VDR KO mice 10 days after 2.5% DSS. Edema (asterisk), cellular inflammation in all layers (arrows).
###end p 111
###begin p 112
###xml 0 41 0 41 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Histology scores in mice treated with DSS</bold>
###xml 20 24 <span type="species:ncbi:10090">mice</span>
###xml 81 85 <span type="species:ncbi:10090">mice</span>
###xml 260 264 <span type="species:ncbi:10090">mice</span>
Histology scores in mice treated with DSS. Colonic injury score in WT and VDR KO mice that received 2.5%DSS at 5 or 10 days post-administration. Scores were determined as described in Materials and Methods. * VDR KO values were significantly different than WT mice at 5 days post-DSS. ** VDR KO values were significantly different than WT at 10 days post-DSS.
###end p 112
###begin p 113
###xml 0 59 0 59 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Cytokine and chemokine production after DSS-induced colitis</bold>
###xml 228 232 <span type="species:ncbi:10090">mice</span>
Cytokine and chemokine production after DSS-induced colitis. TNF-alpha, IL-12, IFN-gamma IL-1alpha, IL-1beta, IL-10, MIP-1alpha, KC protein expression in colonic homogenates. * VDR KO values were significantly different than WT mice at 5 days or ** 10 days post-DSS.
###end p 113
###begin p 114
###xml 0 23 0 23 <bold xmlns:xlink="http://www.w3.org/1999/xlink">LPS induced endotoxemia</bold>
###xml 73 77 <span type="species:ncbi:10090">mice</span>
LPS induced endotoxemia. The survival of VDR KO (n = 11) and WT (n = 10) mice injected i.v. with 10 mg/kg LPS.
###end p 114
###begin p 115
###xml 8 9 8 9 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 10 12 10 12 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 0 35 0 35 <bold xmlns:xlink="http://www.w3.org/1999/xlink">1,25(OH)<sub>2</sub>D<sub>3 </sub>ameliorates DSS colitis</bold>
###xml 37 40 37 40 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A) </bold>
###xml 115 116 115 116 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 117 119 117 119 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 138 141 138 141 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B) </bold>
###xml 214 217 214 217 <bold xmlns:xlink="http://www.w3.org/1999/xlink">C) </bold>
###xml 345 348 345 348 <bold xmlns:xlink="http://www.w3.org/1999/xlink">D) </bold>
###xml 132 136 <span type="species:ncbi:10090">mice</span>
###xml 208 212 <span type="species:ncbi:10090">mice</span>
###xml 285 289 <span type="species:ncbi:10090">mice</span>
###xml 405 409 <span type="species:ncbi:10090">mice</span>
1,25(OH)2D3 ameliorates DSS colitis. A) IL-10 production from the colonic homogenates of control (CTRL) or 1,25(OH)2D3 (1,25D3) fed mice. B) Total histological score was determined for control and 1,25D3 fed mice. C) Percent weight change of CTRL (n = 6) or 1,25D3 (n = 10) treated WT mice when the treatment was given rectally every other day. D) Colonic injury score in rectally treated CTRL and 1,25D3 mice at 10 days post-DSS. *CTRL and 1,25D3 values were significantly different at the corresponding time points.
###end p 115

